» Articles » PMID: 18256597

Prevalence and Severity of Disordered Mineral Metabolism in Blacks with Chronic Kidney Disease

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2008 Feb 8
PMID 18256597
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Disorders of mineral metabolism develop early in chronic kidney disease, but it appears that Blacks with stage-5 disease have more severe secondary hyperparathyroidism than other races. We measured levels of parathyroid hormone, calcium, phosphorus, 25-hydroxyvitamin D (25D) and 1,25-dihydroxyvitamin D (1,25D) in 227 Black and 1633 non-Black participants in the SEEK study, a multi-center cohort of patients with early chronic kidney disease. Overall, Blacks had similar 1,25D levels compared with non-Blacks, but significantly lower levels of 25D with higher levels of calcium, phosphorus, and parathyroid hormone, and were significantly more likely to have hyperphosphatemia than non-Blacks. In multivariable analyses adjusted for age, gender, estimated glomerular filtration rate, body mass index, and diabetes, Blacks had significantly lower 25D and higher parathyroid hormone levels than non-Blacks, with the latter parameter remaining significant after further adjustment for calcium, phosphorus, 25D, and 1,25D. The association between Black race and secondary hyperparathyroidism, independent of known risk factors, suggests that novel mechanisms contribute to secondary hyperparathyroidism in Blacks with chronic kidney disease.

Citing Articles

Ethnic and seasonal variations in FGF-23 and markers of chronic kidney disease-mineral and bone disorder.

Taskapan H, Mahdavi S, Bellasi A, Martin S, Kuvadia S, Patel A Clin Kidney J. 2024; 17(7):sfae188.

PMID: 39070948 PMC: 11273220. DOI: 10.1093/ckj/sfae188.


Estimating the global prevalence of secondary hyperparathyroidism in patients with chronic kidney disease.

Wang Y, Liu J, Fang Y, Zhou S, Liu X, Li Z Front Endocrinol (Lausanne). 2024; 15:1400891.

PMID: 38974573 PMC: 11224516. DOI: 10.3389/fendo.2024.1400891.


Black patients are more likely to undergo parathyroidectomy for secondary hyperparathyroidism.

Udyavar N, Ahn J, Crepeau P, Morris-Wiseman L, Thompson V, Chen Y Surgery. 2022; 173(1):111-116.

PMID: 36195501 PMC: 10443691. DOI: 10.1016/j.surg.2022.05.040.


Fibroblast Growth Factor 23 (FGF 23) and intact parathyroid hormone (iPTH) as markers of mineral bone disease among Nigerians with non-diabetic kidney disease.

Raji Y, Ajayi S, Adeoye A, Amodu O, Tayo B, Salako B Afr Health Sci. 2022; 22(1):344-351.

PMID: 36032486 PMC: 9382529. DOI: 10.4314/ahs.v22i1.42.


Modulation of cardiometabolic risk and CardioRenal syndrome by oral vitamin D supplementation in Black and White Southern Sahara residents with chronic kidney disease Stage 3: focus on racial and ethnic disparities.

Bouazza A, Tahar A, AitAbderrhmane S, Saidani M, Koceir E Ren Fail. 2022; 44(1):1243-1262.

PMID: 35930297 PMC: 9359195. DOI: 10.1080/0886022X.2022.2106244.